Modeling conformational transitions in kinases by molecular dynamics simulations: achievements, difficulties, and open challenges

Protein kinases work because their flexibility allows to continuously switch from inactive to active form. Despite the large number of structures experimentally determined in such states, the mechanism of their conformational transitions as well as the transition pathways are not easily to capture. In this regard, computational methods can help to shed light on such an issue. However, due to the intrinsic sampling limitations, much efforts have been done to model in a realistic way the conformational changes occurring in protein kinases. In this review we will address the principal biological achievements and structural aspects in studying kinases conformational transitions and will focus on the main challenges related to computational approaches such as molecular modeling and MD simulations.

[1]  B. O. SKIPP.  Big guns , 1990, Nature.

[2]  Michael J. Eck,et al.  Three-dimensional structure of the tyrosine kinase c-Src , 1997, Nature.

[3]  C. Wermuth,et al.  Glossary of terms used in medicinal chemistry (IUPAC Recommendations 1998) , 1998 .

[4]  Wenqing,et al.  Three-dimensional structure of the tyrosine kinase cSrc , 2022 .

[5]  Lynn F. Ten Eyck,et al.  A helix scaffold for the assembly of active protein kinases , 2008, Proceedings of the National Academy of Sciences.

[6]  J. Kuriyan,et al.  The Conformational Plasticity of Protein Kinases , 2002, Cell.

[7]  Sung-Hou Kim,et al.  Crystal structure of cyclin-dependent kinase 2 , 1993, Nature.

[8]  R. Dror,et al.  A conserved protonation-dependent switch controls drug binding in the Abl kinase , 2009, Proceedings of the National Academy of Sciences.

[9]  L. Meijer,et al.  Inverse in silico screening for identification of kinase inhibitor targets. , 2007, Chemistry & biology.

[10]  Oliver F. Lange,et al.  Kinetics of conformational sampling in ubiquitin. , 2011, Angewandte Chemie.

[11]  Andrea Amadei,et al.  Molecular mechanisms of activation in CDK2 , 2014, Journal of biomolecular structure & dynamics.

[12]  M. Waldrop.  X-ray science: The big guns , 2014, Nature.

[13]  L. Johnson,et al.  Protein Kinase Inhibitors: Insights into Drug Design from Structure , 2004, Science.

[14]  A. Duhme-Klair,et al.  The background, discovery and clinical development of BCR-ABL inhibitors. , 2013, Drug discovery today.

[15]  P. Ronald,et al.  Plant and Animal Pathogen Recognition Receptors Signal through Non-RD Kinases , 2006, PLoS pathogens.

[16]  Ashutosh Kumar,et al.  Knowledge Based Identification of Potent Antitubercular Compounds Using Structure Based Virtual Screening and Structure Interaction Fingerprints , 2009, J. Chem. Inf. Model..

[17]  Oliver Hantschel,et al.  Regulation of the c-Abl and Bcr–Abl tyrosine kinases , 2004, Nature Reviews Molecular Cell Biology.

[18]  John Kuriyan,et al.  Crystal structure of the Src family tyrosine kinase Hck , 1997, Nature.

[19]  L. Meijer,et al.  Therapeutics , Targets , and Chemical Biology Indirubin Derivative 6 BIO Suppresses Metastasis , 2013 .

[20]  Lester A. Mitscher,et al.  Glossary of terms used in medicinal chemistry , 1998 .

[21]  Susan S. Taylor,et al.  Regulation of protein kinases; controlling activity through activation segment conformation. , 2004, Molecular cell.

[22]  Susan S. Taylor,et al.  Surface comparison of active and inactive protein kinases identifies a conserved activation mechanism , 2006, Proceedings of the National Academy of Sciences.

[23]  S. Wulf,et al.  Amendment history : Corrigendum ( November 2013 ) An anticancer C-Kit kinase inhibitor is reengineered to make it more active and less cardiotoxic , 2018 .

[24]  Susan S. Taylor,et al.  Defining the Conserved Internal Architecture of a Protein Kinase , 2010, Biochimica et biophysica acta.

[25]  Bradley M Dickson,et al.  αC helix as a switch in the conformational transition of Src/CDK-like kinase domains. , 2012, The journal of physical chemistry. B.

[26]  Elizabeth J. Denning,et al.  Zipping and unzipping of adenylate kinase: atomistic insights into the ensemble of open<-->closed transitions. , 2009, Journal of molecular biology.

[27]  Benoît Roux,et al.  Mapping the conformational transition in Src activation by cumulating the information from multiple molecular dynamics trajectories , 2009, Proceedings of the National Academy of Sciences.

[28]  A. Giordano,et al.  Cell cycle kinases as therapeutic targets for cancer , 2009, Nature Reviews Drug Discovery.

[29]  Susan S. Taylor,et al.  Crystal structure of a transition state mimic of the catalytic subunit of cAMP-dependent protein kinase , 2002, Nature Structural Biology.

[30]  John Kuriyan,et al.  A Src-Like Inactive Conformation in the Abl Tyrosine Kinase Domain , 2006, PLoS biology.

[31]  L. Johnson,et al.  The crystal structure of a phosphorylase kinase peptide substrate complex: kinase substrate recognition , 1997, The EMBO journal.

[32]  Albert C. Pan,et al.  Transitions to catalytically inactive conformations in EGFR kinase , 2013, Proceedings of the National Academy of Sciences.

[33]  L. Johnson,et al.  The structural basis for control of eukaryotic protein kinases. , 2012, Annual review of biochemistry.

[34]  W. Wooster,et al.  Crystal structure of , 2005 .

[35]  He Huang,et al.  A Comparison of Three Perturbation Molecular Dynamics Methods for Modeling Conformational Transitions. , 2009, Journal of chemical theory and computation.

[36]  G. Lolli.  Structural dissection of cyclin dependent kinases regulation and protein recognition properties , 2010, Cell cycle.

[37]  Nanxin Li,et al.  Discovery of GNF-5837, a Selective TRK Inhibitor with Efficacy in Rodent Cancer Tumor Models. , 2012, ACS medicinal chemistry letters.